450
Participants
Start Date
June 11, 2009
Primary Completion Date
January 11, 2010
Study Completion Date
January 11, 2010
GSK Biologicals' Synflorix™ (Pneumococcal vaccine GSK1024850A)
Intramuscular injection, administered as a single dose
Wyeth-Lederle's Prevenar™
Intramuscular injection, administered as a single dose
GSK Biologicals' Hiberix™
Intramuscular injection, administered as a single dose
GSK Investigational Site, Ansan
GSK Investigational Site, Bucheon-Si, GyeongGi-do,
GSK Investigational Site, Daejeon
GSK Investigational Site, Gyeonggi-do
GSK Investigational Site, GyeongSangNam-do
GSK Investigational Site, Iksan
GSK Investigational Site, Jeju City
GSK Investigational Site, Jeonju Jeonbuk
GSK Investigational Site, Pusan
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon City, Gyeonggi-do
GSK Investigational Site, Wonju-si Kangwon-do
Lead Sponsor
GlaxoSmithKline
INDUSTRY